1472
     RDKit          3D

 12 12  0  0  1  0  0  0  0  0999 V2000
    1.0225    0.1478   -0.0968 O   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4447   -1.8092   -2.7974 N   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2757   -2.6679   -3.7645 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.6740   -2.9987   -3.1840 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.3415   -1.9333   -2.8272 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.4988   -3.7649   -4.2174 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.1594   -2.5282   -2.3729 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6257   -0.6207   -2.4246 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.6973   -1.8425   -1.5000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7948    0.0463   -1.5304 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3603   -0.5619   -1.0564 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4374    0.0505   -0.1100 C   0  0  0  0  0  0  0  0  0  0  0  0
  1 11  1  0
  1 12  1  0
  2  4  1  0
  3  4  1  0
  3  5  1  0
  4  6  1  0
  5  7  2  0
  5  8  1  0
  7  9  1  0
  8 10  2  0
  9 11  2  0
 10 11  1  0
M  END
>  <DRUGBANK_ID>  (1) 
DB01472

>  <SECONDARY_ACCESSION_NUMBERS>  (1) 
EXPT03303

>  <COMMON_NAME>  (1) 
4-Methoxyamphetamine

>  <CAS_NUMBER>  (1) 
64-13-1

>  <UNII>  (1) 
OVB8F8P39Q

>  <SYNONYMS>  (1) 
(2RS)-1-(4-methoxyphenyl)propan-2-amine; 4-methoxyamfetamine; D,L-p-methoxyamphetamine; Formoterol fumarate related compound G; P-methoxyamfetamine; P-methoxyamphetamine; Paramethoxyamphetamine

$$$$
